EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endothelial insulin-like growth factor-1 signalling regulates vascular barrier function and atherogenesis

Michael Drozd iD, Alexander-Francisco Bruns, Nadira Y Yuldasheva, Azhar Maqbool iD, Hema Viswambharan, Anna Skromna, Natallia Makava, Chew W Cheng, Piruthivi Sukumar, Lauren Eades, Andrew M N Walker, Kathryn J Griffin und 11 weitere

Cardiovascular Research · 2025

DOI: 10.1093/cvr/cvaf055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Michael Drozd und 22 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Cardiovascular and Metabolic Medicine, LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds LS2 9JT, UK. Hauptthemen laut MEDLINE: Atherosclerosis, Capillary Permeability, Receptor, IGF Type 1, Human Umbilical Vein Endothelial Cells. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Biotechnology and Biological Sciences Research Council, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Progressive deposition of cholesterol in the arterial wall characterizes atherosclerosis, which underpins most cases of myocardial infarction and stroke. Insulin-like growth factor-1 (IGF-1) is a hormone that regulates systemic growth and metabolism and possesses anti-atherosclerotic properties. We asked whether endothelial-restricted augmentation of IGF-1 signalling is sufficient to suppress atherogenesis. Methods and results We generated mice with endothelial-restricted over-expression of human wild-type (WT) IGF-1R (hIGFREO/ApoE−/−) or a signalling-defective K1003R mutant human IGF-1R (mIGFREO/ApoE−/−) and compared them with their respective ApoE−/− littermates. hIGFREO/ApoE−/− had less atherosclerosis, circulating leucocytes, arterial cholesterol uptake, and vascular leakage in multiple organs, whereas mIGFREO/ApoE−/− did not exhibit these phenomena. Over-expressing WT IGF-1R in human umbilical vein endothelial cells (HUVECs) altered the localization of tight junction proteins and reduced paracellular leakage across their monolayers, whilst over-expression of K1003R IGF-1R did not have these effects. Moreover, only over-expression of WT IGF-1R reduced HUVEC internalization of cholesterol-rich low-density lipoprotein particles and increased their association of these particles with clathrin, but not caveolin-1, implicating it in vesicular uptake of lipoproteins. Endothelial over-expression of WT vs. K1003R IGF-1R also reduced expression of YAP/TAZ target genes and nuclear localization of TAZ, which may be relevant to its impact on vascular barrier and atherogenesis.

Conclusion

Endothelial IGF-1 signalling modulates both para- and transcellular vascular barrier function. Beyond reducing atherosclerosis, this could have relevance to many diseases associated with abnormal vascular permeability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisCapillary PermeabilityReceptor, IGF Type 1Human Umbilical Vein Endothelial CellsInsulin-Like Growth Factor IAortic DiseasesAnimalsSignal TransductionHumansDisease Models, AnimalMice, Knockout, ApoECholesterolMice, Inbred C57BLYAP-Signaling ProteinsCells, CulturedAdaptor Proteins, Signal TransducingPlaque, AtheroscleroticTight JunctionsCell Cycle ProteinsMaleInsulin-Like Peptides

Stichwörter der Autor:innen

AtherosclerosisEndothelialInsulin-like growth factor-1 receptorVascular permeability

Substanzen

Receptor, IGF Type 1IGF1R protein, humanInsulin-Like Growth Factor IIGF1 protein, humanCholesterolYAP-Signaling ProteinsIgf1r protein, mouseAdaptor Proteins, Signal TransducingYap1 protein, mouseCell Cycle Proteins

Autor:innen und Institutionen

  • Leeds Institute of Cardiovascular and Metabolic Medicine, LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds LS2 9JT, UK.

ORCID-Profile: Michael Drozd, Azhar Maqbool, Natalie Haywood, Richard M Cubbon

Förderung

  • Wellcome Trust
  • Biotechnology and Biological Sciences Research Council
  • British Heart Foundation

Zitieren

APA

Drozd, M., Bruns, A. F., Yuldasheva, N. Y., Maqbool, A., Viswambharan, H., Skromna, A., Makava, N., Cheng, C. W., Sukumar, P., Eades, L., Walker, A. M. N., Griffin, K. J., Galloway, S., Watt, N. T., Haywood, N., Palin, V., Warmke, N., Imrie, H., Bridge, K., …, & Cubbon, R. M. (2025). Endothelial insulin-like growth factor-1 signalling regulates vascular barrier function and atherogenesis. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf055

Vancouver

Drozd M, Bruns AF, Yuldasheva NY, Maqbool A, Viswambharan H, Skromna A, et al. Endothelial insulin-like growth factor-1 signalling regulates vascular barrier function and atherogenesis. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf055

BibTeX
@article{Drozd2025,
  author = {Drozd, Michael and Bruns, Alexander-Francisco and Yuldasheva, Nadira Y and Maqbool, Azhar and Viswambharan, Hema and Skromna, Anna and Makava, Natallia and Cheng, Chew W and Sukumar, Piruthivi and Eades, Lauren and Walker, Andrew M N and Griffin, Kathryn J and Galloway, Stacey and Watt, Nicole T and Haywood, Natalie and Palin, Victoria and Warmke, Nele and Imrie, Helen and Bridge, Katherine and Beech, David J and Wheatcroft, Stephen B and Kearney, Mark T and Cubbon, Richard M},
  title = {Endothelial insulin-like growth factor-1 signalling regulates vascular barrier function and atherogenesis},
  journal = {Cardiovascular Research},
  year = {2025},
  doi = {10.1093/cvr/cvaf055}
}
Kostenlos starten →